These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3080860)

  • 1. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
    Woosley RL; Echt DS; Roden DM
    Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure.
    Woosley RL
    Am Heart J; 1987 Nov; 114(5):1280-91. PubMed ID: 3314444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites of cardiac antiarrhythmic drugs: their clinical role.
    Kates RE
    Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG
    Eur Heart J; 1984 Sep; 5 Suppl B():63-6. PubMed ID: 6437818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolites of antiarrhythmic drugs: are they clinically important?
    Kates RE
    Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
    Gottlieb SS; Kukin ML; Medina N; Yushak M; Packer M
    Circulation; 1990 Mar; 81(3):860-4. PubMed ID: 2106401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of antiarrhythmic drugs.
    Block PJ; Winkle RA
    Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of old and new antiarrhythmic drugs.
    Siddoway LA; Roden DM; Woosley RL
    Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse hemodynamic effects of antiarrhythmic drugs in congestive heart failure.
    Hammermeister KE
    Circulation; 1990 Mar; 81(3):1151-3. PubMed ID: 2106400
    [No Abstract]   [Full Text] [Related]  

  • 16. Reliability of antiarrhythmic drug plasma concentration monitoring.
    Follath F; Ganzinger U; Schuetz E
    Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drugs.
    Roy D
    Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S65-7. PubMed ID: 2872953
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of antiarrhythmic drugs.
    Harrison DC; Meffin PJ; Winkle RA
    Prog Cardiovasc Dis; 1977; 20(3):217-42. PubMed ID: 335439
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of metabolites in antiarrhythmic therapy.
    Woosley RL; Roden DM
    Am J Cardiol; 1983 Sep; 52(6):3C-7C. PubMed ID: 6194679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.